Trial | Variance | Relative Changes | |
---|---|---|---|
\(\boldsymbol\rho\boldsymbol=\mathbf0\) | \(\boldsymbol\rho\boldsymbol=\boldsymbol o\boldsymbol b\boldsymbol s\boldsymbol e\boldsymbol r\boldsymbol v\boldsymbol e\boldsymbol d\) | ||
BR.10 | 1,744,993 | 1,690,399 | 3% |
BR.21 | 21,792 | 20,318 | 7% |
LY.12 | 6,922 | 6,800 | 2% |
CO.17 (all patients) | 8,571 | 5,477 | 36% |
CO.17 (KRAS subgroup) | 22,780 | 14,610 | 36% |